We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TCBI:NASDAQTexas Capital Bancshares, Inc. Analysis

Data as of 2026-09-01 - not real-time

$97.18

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Texas Capital Bancshares, Inc. is priced at $97.18, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 6.1%. RSI sits at 37.5, which reads as approaching oversold, and MACD momentum is bearish. Price has been bracketed by support at $96.72 and resistance at $102.79.
The shares look undervalued, trading on 12.8 times earnings below a sector average of 16.9. Analyst price targets sit 12.5% above the current price. Revenue is growing at 8.6% on a 28.7% profit margin. The 0.82% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 17.7%, a beta of 0.89 and a maximum drawdown of 14.2%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.

Top Market Events

Second quarter2026 net income available to common stockholders of $80.Yahoo Finance1monTexas Capital Bancshares, Inc.This August 18 story has been repeated with no changes to the text.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 98.02
  • MACD momentum is negative
  • 30-day price change of -6.1%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 12.8 versus sector average of 16.9
  • Trading below the 200-day average of 98.02
  • Analyst targets imply +12.5% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 12.8 versus sector average of 16.9
  • Analyst targets imply +12.5% versus the current price
  • Profit margin of 28.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin28.70%
P/E Ratio12.8
ROE10.19%
ROA1.11%
P/B Ratio1.3
Op. Cash Flow$487.8M
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI37.5
Support$96.72
Resistance$102.79
MA 20$99.36
MA 50$101.03
MA 200$98.02
MACDBearish
VolumeIncreasing
Fear & Greed Index93.11

Valuation

Fair Value$206.07
Target Price$109.31
Upside/Downside12.48%
GradeUndervalued
TypeBlend
Dividend Yield0.82%

Risk Assessment

Beta0.89
Volatility17.67%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.